HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lymphocytotoxicity against autologous hepatocytes and membrane-bound IgG in viral and autoimmune chronic active hepatitis.

Abstract
Membrane-bound IgG and lymphocytotoxic activity of total, T-enriched and T-depleted lymphocytes, using autologous hepatocytes have been evaluated in: (a) 31 patients with chronic active hepatitis (CAH) (six autoimmune and 25 hepatitis B virus - HBV-related); (b) five patients with inactive alcoholic cirrhosis; and (c) nine subjects with normal hepatic histology. Lymphocytotoxicity was positive in 83% of autoimmune CAH and 68% of HBV-related cases; it was confined to the T-depleted subpopulation in the first group, while it was present in both the T-enriched and T-depleted subpopulations in 81% of HBV-related cases. Membrane-bound IgG was present in 58% of group (a) and in none of the other groups. A linear pattern was found in four out of five autoimmune CAH patients with positive lymphocytotoxic activity. The autoimmune patient with lymphocytotoxic activity within the normal range did not show any membrane fluorescence. Among HBV-related CAH patients, 13 presented a granular pattern, two an associated granular and linear pattern and ten were negative. These data suggest that different lymphocytotoxic mechanisms are involved in the two forms of CAH studied.
AuthorsG F Stefanini, R Meliconi, F Miglio, M Mazzetti, M Baraldini, A Facchini, G Gasbarrini
JournalLiver (Liver) Vol. 3 Issue 1 Pg. 36-45 (Feb 1983) ISSN: 0106-9543 [Print] Denmark
PMID6602263 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Autoantibodies
  • Hepatitis B Surface Antigens
  • Immunoglobulin G
Topics
  • Autoantibodies (analysis)
  • Hepatitis B (immunology)
  • Hepatitis B Surface Antigens (analysis)
  • Hepatitis, Chronic (immunology)
  • Humans
  • Immunoglobulin G (analysis)
  • Liver (immunology)
  • Liver Cirrhosis, Alcoholic (immunology)
  • T-Lymphocytes, Cytotoxic (immunology, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: